These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17557913)
21. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884 [TBL] [Abstract][Full Text] [Related]
22. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681 [TBL] [Abstract][Full Text] [Related]
23. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Ros J; Clària J; To-Figueras J; Planagumà A; Cejudo-Martín P; Fernández-Varo G; Martín-Ruiz R; Arroyo V; Rivera F; Rodés J; Jiménez W Gastroenterology; 2002 Jan; 122(1):85-93. PubMed ID: 11781284 [TBL] [Abstract][Full Text] [Related]
24. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Wang Q; Peng Y; Chen S; Gou X; Hu B; Du J; Lu Y; Xiong L Stroke; 2009 Jun; 40(6):2157-64. PubMed ID: 19372445 [TBL] [Abstract][Full Text] [Related]
25. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. Ho WS; Patel S; Thompson JR; Roberts CJ; Stuhr KL; Hillard CJ Br J Pharmacol; 2010 Jun; 160(3):736-46. PubMed ID: 20590576 [TBL] [Abstract][Full Text] [Related]
26. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. Akerman S; Kaube H; Goadsby PJ J Pharmacol Exp Ther; 2004 Apr; 309(1):56-63. PubMed ID: 14718591 [TBL] [Abstract][Full Text] [Related]
27. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864 [TBL] [Abstract][Full Text] [Related]
28. Endocannabinoids and their role in fatty liver disease. Mallat A; Lotersztajn S Dig Dis; 2010; 28(1):261-6. PubMed ID: 20460921 [TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Wagner JA; Járai Z; Bátkai S; Kunos G Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486 [TBL] [Abstract][Full Text] [Related]
30. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. Wagner JA; Abesser M; Harvey-White J; Ertl G J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503 [TBL] [Abstract][Full Text] [Related]
31. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778 [TBL] [Abstract][Full Text] [Related]
32. The endocannabinoid system mediates aerobic exercise-induced antinociception in rats. Galdino G; Romero TR; Silva JF; Aguiar DC; de Paula AM; Cruz JS; Parrella C; Piscitelli F; Duarte ID; Di Marzo V; Perez AC Neuropharmacology; 2014 Feb; 77():313-24. PubMed ID: 24148812 [TBL] [Abstract][Full Text] [Related]
33. Endocannabinoid modulation of male rat sexual behavior. Gorzalka BB; Morrish AC; Hill MN Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389 [TBL] [Abstract][Full Text] [Related]
34. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299 [TBL] [Abstract][Full Text] [Related]
35. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347 [TBL] [Abstract][Full Text] [Related]
36. Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion. Fernandez-Solari J; Prestifilippo JP; Ossola CA; Rettori V; Elverdin JC Arch Oral Biol; 2010 Aug; 55(8):583-90. PubMed ID: 20542488 [TBL] [Abstract][Full Text] [Related]
37. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. Pacher P; Bátkai S; Kunos G J Physiol; 2004 Jul; 558(Pt 2):647-57. PubMed ID: 15121805 [TBL] [Abstract][Full Text] [Related]
38. Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury. Mukhopadhyay P; Horváth B; Rajesh M; Matsumoto S; Saito K; Bátkai S; Patel V; Tanchian G; Gao RY; Cravatt BF; Haskó G; Pacher P Free Radic Biol Med; 2011 Jan; 50(1):179-95. PubMed ID: 21070851 [TBL] [Abstract][Full Text] [Related]
39. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. Giannone FA; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P Lab Invest; 2012 Mar; 92(3):384-95. PubMed ID: 22184091 [TBL] [Abstract][Full Text] [Related]
40. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus. Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]